DJIA 15,914.74 -99.64 -0.62%
NASDAQ 4,283.59 14.83 0.35%
S&P 500 1,851.86 -0.35 -0.02%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

29.04 0.45 (1.57%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AZN $29.04 1.57%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $28.98
Previous Close $28.59
Daily Range $28.94 - $29.38
52-Week Range $28.29 - $36.69
Market Cap $73.4B
P/E Ratio 28.03
Dividend (Yield) $0.90 (4.8%)
Ex-Dividend Date
Dividend Pay Date
02/17/16
03/21/16
Volume 4,789,753
Average Daily Volume 5,039,933
Current FY EPS $2.14

Sector

Healthcare

Industry

Drug Makers

AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website: http://www.astrazeneca.com/

News & Commentary

3 Feverishly Bad Flu Myths That Should Be Put to Rest

The flu might be the most misunderstood disease on the planet, and we're putting three of the most common myths to rest today.

Massachusetts-Based Proteostatis Therapeutics IPO: Early Stage And Stiff Competition Keeps Us Cautio

Massachusetts-Based Proteostatis Therapeutics IPO: Early Stage And Stiff Competition Keeps Us Cautious

Therapy Focus- Phase III Proves Tough For IPF

Analysts' Actions -- AstraZeneca, LinkedIn, Salesforce.com, Weibo

AstraZeneca's (AZN) CEO Pascal Soriot on Q4 2015 Results - Earnings Call Transcript

AstraZeneca (AZN) Stock Flailing on Fundamentals, Technicals

AstraZeneca (AZN) Is Weak On High Volume Today

Benzinga's Top Downgrades

Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK, Table

Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK, Tableau and Many More

Pre-Market Most Active for Feb 8, 2016 : CBX, NVS, TVIX, AZN, NOK, MT, BCRX, QQQ, FB, XIV, BAC, APO

Pre-Market Most Active for Feb 8, 2016 : CBX, NVS, TVIX, AZN, NOK, MT, BCRX, QQQ, FB, XIV, BAC, APOL

AbbVie Stands For Abnormally Vulnerable

See More AZN News...

AZN's Top Competitors

AZN $29.04 (1.57%)
Current stock: AZN
JNJ $101.73 (-0.24%)
Current stock: JNJ
PFE $29.49 (1.34%)
Current stock: PFE
NVS $72.99 (0.51%)
Current stock: NVS